Literature DB >> 19437354

Current theories on the pathogenesis of infantile hemangioma.

Kristine Lo1, Martin Mihm, Aaron Fay.   

Abstract

Infantile hemangiomas are the most common tumors of infancy and although the natural history and progression of these lesions are well described, their origin remains unclear. Considerable progress has been achieved in the past two decades towards understanding the etiology of these lesions. New investigations have produced sophisticated hypotheses on the origin of these tumors and their behavior. These include suggestions of placental origin, intrinsic defect or somatic endothelial mutation, and extrinsic factors creating a conducive milieu for growth. While no current hypothesis explains all the characteristics of infantile hemangiomas, continued research targeting pathophysiology will ultimately lead to new treatment options.

Entities:  

Mesh:

Year:  2009        PMID: 19437354     DOI: 10.1080/08820530902805438

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  10 in total

Review 1.  Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-08-26       Impact factor: 3.183

2.  Hypothesis: the metastatic niche theory can elucidate infantile hemangioma development.

Authors:  Martin C Mihm; J Stuart Nelson
Journal:  J Cutan Pathol       Date:  2010-04       Impact factor: 1.587

3.  Transfection of adenovirus-mediated mircoRNA-126 gene into infant hemangioma endothelial cells in vitro.

Authors:  Zhe Cao; Yong-Qiang Guo; Sheng-Jian Tang; Shen-Xing Tan; Chang-Ying Niu; Chun-Lei Miao; Wei Zhang; Yu-Li Li; Long Zhang; Jing-Han Wang; Xiao-Qin Liang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Expression of p16 protein in infantile hemangioma.

Authors:  Shi Wang; Wei Zheng
Journal:  Oncol Lett       Date:  2015-06-24       Impact factor: 2.967

5.  A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.

Authors:  Masayuki Tsuneki; Steven Hardee; Michael Michaud; Raffaella Morotti; Erin Lavik; Joseph A Madri
Journal:  Lab Invest       Date:  2015-05-11       Impact factor: 5.662

6.  Biomechanical properties of infantile hemangiomas: clinical stage and effect of age.

Authors:  M O Visscher; S A Burkes; D M Adams; A Gupta; R R Wickett
Journal:  Skin Res Technol       Date:  2016-06-05       Impact factor: 2.365

7.  Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.

Authors:  Sherief R Janmohamed; Gerard C Madern; Klaske Nieuwenhuis; Peter C J de Laat; Arnold P Oranje
Journal:  Pediatr Surg Int       Date:  2011-12-27       Impact factor: 1.827

8.  Excellent response of infantile orbital hemangioma to propranolol.

Authors:  Fandresena A Sendrasoa; Irina M Ranaivo; Naina H Razanakoto; Malalaniaina Andrianarison; Lala S Ramarozatovo; F Rapelanoro Rabenja
Journal:  Int Med Case Rep J       Date:  2016-11-17

9.  The expression and function of miR-424 in infantile skin hemangioma and its mechanism.

Authors:  Lili Yang; Jun Dai; Fan Li; Henghui Cheng; Dan Yan; Qiurong Ruan
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

10.  Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration.

Authors:  Horacio Gomez-Acevedo; Yuemeng Dai; Graham Strub; Carrie Shawber; June K Wu; Gresham T Richter
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.